Angiotensin-converting enzymes 1 and 2 in the feces: presence and catalytic activity in the rat 2,4,6-trinitrobenzene sulfonic acid-induced model of colitis

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Teresa Maria De Jesus Teixeira De Sousa

    Autor

  • Fernando José Magro Dias

    Autor

Participantes de fora da FMUP

  • Ferreira Duarte, M
  • Oliveira, LCG
  • Quintas, C
  • Dias Pereira, P
  • Casarini, DE
  • Duarte Ara?jo, M
  • Morato, M

Unidades de investigação

Abstract

Background and Aim: Inflammatory bowel disease is challenging to diagnose. Fecal biomarkers offer noninvasive solutions. The renin-angiotensin-aldosterone system is implicated in intestinal inflammation. Angiotensin-converting enzyme (ACE) and angiotensin-converting enzyme 2 (ACE2) regulate its activity, but conflicting findings on these enzymes in colitis require further investigation. We aimed to assess ACE and ACE2 presence and activities in the feces, serum, and colon of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced rats. Methods: Colitis was induced in male rats by rectal instillation of a 21% ethanolic TNBS solution. After rats sacrifice, colonic portions, serum, and feces were collected. ACE and ACE2 presence in the feces was analyzed by western Blot, and colonic and serum enzymes concentrations were quantified using ELISA kits. ACE activity was assessed using Hippuryl-His-Leu and Z-Phe-His-Leu as substrates. ACE2 activity was assessed using Mca-APK (Dnp) as a substrate in the presence and absence of DX600 (ACE2 inhibitor). Results: An ACE isoform of similar to 70 kDa was found only in the feces of TNBS-induced rats. ACE concentration was higher than that of ACE2 in the serum and the inflamed colon. ACE N-domain activity was higher than that of the C-domain in all matrices. ACE2 activity was higher in the feces of TNBS-induced animals compared to controls. Conclusion: A 70 kDa ACE isoform only detected in the feces of TNBS-induced rats may have translational relevance. ACE N-domain seems to play a significant role in regulating colonic lesions. Further research using human samples is necessary to validate these findings.

Dados da publicação

ISSN/ISSNe:
1440-1746, 0815-9319

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY  Wiley-Blackwell Publishing Ltd

Tipo:
Article
Páginas:
1885-1894
Link para outro recurso:
www.scopus.com

Documentos

  • Não há documentos

Métricas

Filiações

Filiações não disponíveis

Keywords

  • angiotensin-converting enzyme (ACE); angiotensin-converting enzyme 2 (ACE2); colitis; feces; isoforms

Proyectos asociados

Gut microbiome and IBD therapy: an interplay?

Investigador Principal: Fernando José Magro Dias

Estudo Observacional Académico (GutIBD) . 2021

Iron deficiency and inflammatory bowel disease. Correlation with inflammation and Vitamin D status.

Investigador Principal: Fernando José Magro Dias

Estudo Observacional Académico (IronIBD) . 2021

Looking 4WARD: The role of dipeptidyl peptidase 4 (DPP-4) in inflammatory bowel disease (IBD) as a novel biomarker for predicting disease activity and monitoring response to therapy in IBD patients.

Investigador Principal: Fernando José Magro Dias

Estudo Observacional Académico (4WARD) . 2021

Unresolved inflammation and endothelitis in severe COVID-19 patients: identification of risk stratification biomarkers and therapeutic targets. (severe COVID-19)

Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa

Estudo Clínico Académico (Severe COVID-19) . FCT . 2020

Endocan: a novel biomarker for risk stratification, prognosis, and therapeutic monitoring in human cardiovascular and renal diseases

Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa

Estudo Clínico Académico (Endocan) . 2020

Renal renin-angiotensin system activation in acute heart failure and its association with endothelial dysfunction, inflammation and oxidative stress.

Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa

Estudo Clínico Académico (Renal) . 2021

Isolated Ulceration of Crohn’s Anastomosis

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico . 2021

Urinary cysteinyl leukotrienes as biomarkers of endothelial activation, inflammation and oxidative stress and their relationship with organ dysfunction in human septic shock

Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa

Estudo Clínico Académico . 2021

Evaluation of 11-dehydro-thromboxane B2 as a biomarker of severity and putative therapeutic target in human acute heart failure and cardiogenic shock

Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa

Estudo Clínico Académico . 2022

Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico . 2022

Endothelial dysfunction in different stages of diseases severity of COVID-19: focus on endocan and arterial hypertension

Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa

Estudo Clínico Académico . 2022

Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients

Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa

Estudo Clínico Académico . 2022

Burden of Inflammatory Bowel Disease in Portugal

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico (Inflammatory Bowel) . 2023

Therapeutic Drug Monitoring: An Emergent Approach in Inflammatory Bowel Disease

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico . 2021

Contributo da endoscopia, biomarcadores e imagiologia na evolução clinica dos doentes com doença inflamatória intestinal

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico . 2019

Citar a publicação

Partilhar a publicação